Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) EBITDA Margin (2009 - 2026)

Updated

Immucell (ICCC) posted EBITDA Margin of 17.66% for Q3 2026, up 3.81 percentage points from 13.86% a year earlier but down 15.85 percentage points from the prior quarter.

Analysis

Immucell (ICCC) EBITDA Margin (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, EBITDA Margin at Immucell was 21.06%, up 2.44 percentage points year-over-year; for FY2025, it came in at 16.30%, up 11.96 percentage points from FY2024.

  • Annual EBITDA Margin shows a five-year change of +9.21 percentage points (FY2020 to FY2025).
  • In prior years, Immucell's EBITDA Margin was 4.35% in FY2024 (+21.33 pp), -16.98% in FY2023 (-18.18 pp), 1.20% in FY2022 (-13.11 pp) and 14.31% in FY2021 (+7.21 pp).
  • Quarterly EBITDA Margin has run from a low of -46.15% in Q1 2023 to a high of 33.52% in Q2 2026 over five years.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last three quarters, with an average year-over-year change of +10.29 percentage points over the last seven quarters.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2024, with a gain of 51.56 percentage points; the weakest was Q1 2023, with a drop of 66.16 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was 33.52% (Q2 2026), 24.18% (Q1 2026) and 8.65% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 32.68%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 46.88%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 40.60%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 39.77%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 46.62%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 50.63%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 42.49%
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 17.66%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17.66%
Jun 30, 2026 33.52%
Mar 31, 2026 24.18%
Dec 31, 2025 8.65%
Sep 30, 2025 13.86%
Jun 30, 2025 19.62%
Mar 31, 2025 22.56%
Dec 31, 2024 17.05%
Sep 30, 2024 2.11%
Jun 30, 2024 -12.59%
Mar 31, 2024 5.41%
Sep 30, 2023 -8.55%
Jun 30, 2023 -17.30%
Mar 31, 2023 -46.15%
Dec 31, 2022 -26.10%
Sep 30, 2022 0.50%
Jun 30, 2022 0.49%
Mar 31, 2022 20.01%
Dec 31, 2021 13.84%
Sep 30, 2021 17.40%
API Access

Immucell EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY